|
|
|
|
LEADER |
01160nam a2200241 a 4500 |
001 |
791805 |
005 |
20171111231201.0 |
008 |
030910s2002 gr r 000 0 eng d |
020 |
|
|
|a 9282867161
|
040 |
|
|
|a GR-KoDPT
|b gre
|e AACR2
|
050 |
|
|
|a R854.E85
|b I47 2002
|
245 |
0 |
0 |
|a Impact assessment of the Biomedical and Health Research Programme BIOMED 2 (1994-98) :
|b framework programme 4 /
|c European Commission, Research Directorate-General, Health research
|
246 |
1 |
3 |
|a BIOMED 2 impact assessment
|
260 |
|
|
|a Biomedical and Health Research Programme
|b Office for Official Publications of the European Communities ,
|c 2002
|a Luxembourg:
|
300 |
|
|
|a 328 σ. ;
|c 24 εκ.
|
500 |
|
|
|a Περιέχει ευρετήριο
|
650 |
|
0 |
|a Medicine
|x Research
|z European Union countries
|
650 |
|
0 |
|a Medicine
|x Research
|z European Union countries
|x Government policy
|
650 |
|
0 |
|a Biology
|x Research
|z European Union countries
|
710 |
|
|
|a Office for Official Publications of the European Communities
|
710 |
0 |
|
|a European Commission.
|b Directorate-General for Research
|
710 |
2 |
|
|a BIOMED2 Programme
|
952 |
|
|
|a GR-KoDPT
|b 59cc2e576c5ad13446fa9546
|c 998a
|d 945l
|e R 854
|t 1
|x m
|z Books
|